The research reveals a key molecular pathway that promotes pain sensation in endometriosis and suggests that migraine treatments targeting this pathway might be effective for endometriosis.
Current treatments for endometriosis are limited, often ineffective, and sometimes have undesirable side effects, highlighting the urgent need for innovative therapies.
Endometriosis research is significantly underfunded compared to other diseases with similar prevalence and economic impact, which hampers progress in developing effective treatments.
Louise Hull states, 'This is a new way of looking at how we could change pain pathways in endometriosis,' indicating a paradigm shift in treatment approaches.
Collection
[
|
...
]